Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » DolirhumePro


Contraindicated
As a precautionary measure

Contraindicated
Cardiovascular and neurological effects
DolirhumePro :
Type Medicine Withdrawn
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Aventis
Origin France
Manufacturer Sanofi Winthrop Industrie
Origin France
ATC R05X

Your comment will appear shortly after approval

DolirhumePro :

Revision Date : 30/11/2015


Effect Frequency
Accommodation disorder Not known
Agitation Not known
Anaphylactic shock Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Angle closure glaucoma Not known
Anxiety Not known
Behavior disorder Not known
Cephalea Not known
Colitis ischaemic Not known
Constipation Not known
Convulsion Not known
Dry mouth (Xerostomia) Not known
Dysuria (Micturition painful) Not known
Erythema Rare
Exanthema Not known
Haemorrhagic transformation stroke Very rare
Hallucination Not known
Hypersensitivity reactions Rare
Hypertension Not known
Insomnia Not known
Ischemic stroke Not known
Leucopenia (Leukopenia) Very rare
Myocardial infarction Not known
Nausea Not known
Neutropenia Very rare
Palpitations Not known
Pruritus Not known
Skin rash Rare
Somnolence Not known
Sweating Not known
Tachycardia Not known
Thrombocytopenic hemorrhage Very rare
Urinary retention Not known
Urticaria Not known
Vomiting Not known

Different Units By MoH Code

Revision Date : 01/07/2015

DolirhumePro DolirhumePro DolirhumePro DolirhumePro DolirhumePro DolirhumePro

DolirhumePro  MoH 7817 :
Form Tablet
Packaging Blisters (Al/PVC)
Package Size Box of 16
Strength 7.5mg/500mg/30mg
NSSF ✘
Quarantine ✘
Reg. Number 222910/14
Submission date 01/01/2014
Registration Year 2014
Archived Date 12/12/2024
Withdrawn Date 03/07/2025


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info